Efficacy of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

Startseite Know-how Efficacy of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

Efficacy of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

This work shows the results of two studies where the safety and the efficacy of SUISENG® (a vaccine against the Neonatal Piglet Colibacillosis, C. perfringens and C. novyi enterotoxicosis) were assessed. Applying the basic vaccination scheme to pregnant sows, the efficacy was evaluated by means the serological response, the transfer of maternal immunity and the clinical signs in challenged piglets with two pathogenic strains of E. coli.

Über diesen Artikel

Verfasser

Liaño, N.; Gibert, X.; Sitjá, M.; Torrents, D.

Zusammenfassung

The results of the two studies demonstrated the efficacy of Suiseng (applying the basic vaccination scheme) against the experimental infection with enterotoxigenic E. coli. The vaccination reduced significantly the clinical signs and the mortality of the piglets suffering from collibacilosis.

Ähnliche Dienstleistungen

Ähnliche Produkte

Teilen